Tag: transdermal estrogen

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Transdermal estrogen shows similar cardiovascular safety profile to traditional luteinizing hormone therapy in patients with prostate cancer

byMichael Pratteand1 others

February 25, 2021

1. The use of long-term transdermal estrogen for castration therapy for prostate cancer showed no difference in cardiovascular events versus ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Guideline-based lymph node sampling is not associated with increased postoperative complications in lung cancer
Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment
Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer

No Result

View All Result